GPR35 and cancer: While recent reviews have comprehensively summarized the molecular basis of GPR35 in cancer and immunity, as well as advances in its therapeutic targeting (28, 29), a focused examination of its role in the metabolic reprogramming of digestive system tumors remains unexplored.